D24 Benign neoplasm of breast

⚠ Non-Billable ICD-10-CM 2026
Open D24 in Web App →

The ICD-10-CM code for Benign neoplasm of breast is D24 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
D10-D36: Benign neoplasms, except benign neuroendocrine tumors (D10-D36)
Category D24
4 codes (3 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D24:

  • Fibroadenoma › cellular intracanalicular
  • Adenoma › nipple
  • Fibroadenoma › phyllodes
  • Cystosarcoma phyllodes › benign
  • Adenomatosis › erosive of nipple
  • Fibroadenoma › giant
  • Fibroadenoma › juvenile
  • Fibroadenoma › unspecified site
Includes
  • benign neoplasm of connective tissue of breast
  • benign neoplasm of soft parts of breast
  • fibroadenoma of breast
Excludes2
Not included here. These conditions are coded elsewhere but may be coded together if applicable.
  • adenofibrosis of breast (N60.2)
  • benign cyst of breast (N60.-)
  • benign mammary dysplasia (N60.-)
  • benign neoplasm of skin of breast (D22.5, D23.5)
  • fibrocystic disease of breast (N60.-)

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial